What Dosage of Mounjaro Causes Weight Loss?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist that prompts meaningful weight reduction across a spectrum of doses. The medication works by reducing hunger signals in your brain, slowing stomach emptying, and improving how your body processes blood sugar. Starting low and increasing gradually helps your body adapt while minimizing side effects.

How Tirzepatide Dosage Affects Weight Loss Results

Tirzepatide's weight loss effect occurs at multiple dose levels, not just at maximum strength. Clinical trials show measurable appetite suppression and weight reduction even at starter doses, with greater effects typically seen as doses increase over 16 to 20 weeks. The relationship between dose and weight loss is dose-dependent, meaning higher doses generally produce larger reductions in body weight over time.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Standard Tirzepatide Dosing Schedule for Weight Management

Tirzepatide injections typically begin at 2.5 mg once weekly, with increases every 4 weeks if well-tolerated. The standard progression moves through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and reaches a maximum of 15 mg weekly. This gradual escalation allows your body to adapt to the medication while tracking tolerance and effectiveness.

The entire titration phase usually spans 16 to 20 weeks, after which you settle into a maintenance dose tailored to your weight loss goals and side effect profile. Maintenance doses range from 5 mg to 15 mg weekly, depending on individual response. PlexusDx compounded tirzepatide is available at a flat monthly rate—your dose may need to go up, but your price won't.

Clinical Evidence Behind Tirzepatide Dosing Effectiveness

A landmark 2022 SUMO trial demonstrated that tirzepatide at 15 mg weekly produced average weight loss of 22.5% of baseline body weight over 72 weeks in patients with obesity. Even lower doses showed clinically meaningful results: the 10 mg dose achieved approximately 21% weight loss, and the 5 mg dose produced around 16% weight loss. These outcomes represent significantly greater reductions than previous GLP-1 only therapies.

Tirzepatide's dual mechanism—targeting both GLP-1 and GIP pathways—explains its superior efficacy at each dose tier. The GIP pathway enhancement appears to amplify appetite suppression and metabolic effects beyond GLP-1 monotherapy. Response is individualized, which is why genetic insights into your GLP1R, GIPR, FTO, and MC4R variants can guide expectations.

Personalizing Your Tirzepatide Dose with Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Armed with genetic data, PlexusDx clinical teams can tailor your starting dose and titration pace to match your biological predispositions. Patients with specific genetic profiles may advance faster through doses or find optimal results at lower maintenance levels. This precision approach reduces guesswork and side effect burden while maximizing weight loss outcomes.

Managing Side Effects While Titrating Tirzepatide

Common side effects during dose escalation include nausea, vomiting, constipation, and fatigue, most often mild and temporary. Spacing out dose increases by 4 weeks allows these effects to resolve naturally in most patients. If side effects persist or worsen, your PlexusDx provider may recommend staying at your current dose longer before advancing.

Staying hydrated, eating smaller frequent meals, and increasing soluble fiber intake reduce gastrointestinal symptoms significantly. Some patients benefit from anti-nausea strategies or temporary dietary adjustments during titration phases. PlexusDx provides ongoing clinical support to help you navigate your dose progression comfortably and reach your target weight loss safely.

PlexusDx Tirzepatide Pricing and Access

PlexusDx compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan) across all dose levels, from 2.5 mg through 15 mg weekly. The flat-rate pricing model means your monthly cost remains consistent whether you're at your starting dose or maintenance dose—no surprise charges as your therapy advances. This transparency helps you budget for your weight loss journey without unexpected expenses.

PlexusDx serves all 50 states without requiring insurance, membership fees, or long-term contracts. All medications come from licensed 503A compounding pharmacies, ensuring quality and compliance. HSA and FSA accounts are accepted, making tirzepatide therapy accessible and affordable for most patients seeking personalized GLP-1 weight loss treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

At what tirzepatide dose do you start losing weight?

Weight loss can begin at the starting 2.5 mg dose, though effects become more pronounced as you titrate upward. Most patients notice meaningful appetite reduction and initial weight loss within 2 to 4 weeks of starting. The degree of weight loss increases progressively through the 16-20 week titration phase, with greatest results typically at higher maintenance doses.

Is 5 mg of tirzepatide enough for weight loss?

Yes—the 5 mg dose produced approximately 16% average weight loss in clinical trials, which is medically significant. Some patients achieve their weight loss goals at 5 mg and choose to maintain this dose rather than escalate further. PlexusDx providers can help you determine whether to continue at 5 mg or advance based on your individual response and goals.

How long does it take tirzepatide to work at each dose level?

Most patients notice appetite suppression within 3 to 7 days of their first injection. Measurable weight loss typically becomes evident within 2 to 4 weeks. Peak effects at each dose level generally emerge around 4 weeks of consistent dosing before advancing to the next tier.

Can I skip tirzepatide dose increases if I'm already losing weight?

Yes—if you're achieving your weight loss goals and tolerating your current dose well, you may remain at that dose indefinitely. PlexusDx supports flexible dosing plans; there's no requirement to reach the 15 mg maximum. Your dose may need to go up, but the decision to increase is based on your progress and comfort, not a preset schedule.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What if I don't tolerate higher tirzepatide doses?

Many patients find their optimal dose below the 15 mg maximum and stay there long-term. If side effects worsen with escalation, you may pause increases, extend the 4-week interval, or return to your previous well-tolerated dose. PlexusDx providers adjust your plan based on your comfort and response, ensuring sustainable weight loss without excessive side effects.

Related Reading

• Mounjaro For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.